Loading
CC
Celgene Corp /DE/ Stock: price and insider trades · United States
Celgene Corp /DE/: what insiders have been doing
Insider filings for Celgene Corp /DE/ are scarce in the SEC (Form 4) feed, the latest one published on 16 February 2016. This page will fill in as new trades are disclosed. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
24
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
RevenueUS$13.2B
Gross profitUS$12.7B96% margin
Net incomeUS$3.5B26.5% margin
Last declaration on 16 February 2016
Declarations24 total
25,840 sharesCommon StockSEC:0001209191-16-098803:0
11,889 sharesCommon StockSEC:0001209191-16-098803:1
29,219 sharesCommon StockSEC:0001209191-16-098806:0
13,746 sharesCommon StockSEC:0001209191-16-098806:1
1,173 sharesCommon StockSEC:0001209191-16-098810:0
1,173 sharesCommon StockSEC:0001209191-16-098810:1
7,822 sharesCommon StockSEC:0001209191-16-098814:0
4,056 sharesCommon StockSEC:0001209191-16-098814:1
2,634 sharesCommon StockSEC:0001209191-16-094811:0
4,528 sharesCommon StockSEC:0001209191-16-094811:1
2,438 sharesCommon StockSEC:0001209191-16-094811:2
1,266 sharesCommon StockSEC:0001209191-16-094811:3
2,500 sharesCommon StockSEC:0001209191-16-094811:4
1,926 sharesCommon StockSEC:0001209191-16-094811:5
2,292 sharesCommon StockSEC:0001209191-16-094811:6
1,128 sharesCommon StockSEC:0001209191-16-094811:7
1,720 sharesCommon StockSEC:0001209191-16-094811:8
1,506 sharesCommon StockSEC:0001209191-16-094811:9
18,600 sharesCommon StockSEC:0001209191-16-094830:0
7,292 sharesCommon StockSEC:0001209191-16-092291:0
4,030 sharesCommon StockSEC:0001209191-16-092291:1
3,970 sharesCommon StockSEC:0001209191-16-092291:2
3,508 sharesCommon StockSEC:0001209191-16-092291:3
3,880 sharesCommon StockSEC:0001209191-16-092291:4
24 of 24 declarations
About Celgene Corp /DE/
Celgene Corp /DE/ is a biopharmaceutical company focused on developing drugs for cancer and inflammatory diseases. It is listed on NASDAQ under the ticker CELG.
